Actively Recruiting
Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation
Led by Barts & The London NHS Trust · Updated on 2026-04-21
141
Participants Needed
1
Research Sites
205 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A prospective, observational cohort study designed to identify clinical phenotypes and evaluate predictors \& outcomes of functional mitral and tricuspid valve regurgitation in patients with atrial fibrillation. Participant will under go: * Baseline echocardiography * Cpex Echocardiography * Blood test: BNP * 1 year follow up Echocardiography Participants will be stratified into three subgroups: * Atrial Functional MR * Atrial Functional TR * Mixed MR \& TR
CONDITIONS
Official Title
Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Informed consent
- Age of 18 years or older
- Diagnosis of atrial fibrillation
- Moderate or severe atrial valve disease
- Adequate 2D echocardiography views including parasternal long axis, short axis, apical two chamber, apical three chamber, and four chamber
You will not qualify if you...
- Unwilling or unable to give consent
- Left ventricular impairment with ejection fraction less than 50%
- Primary or organic valve disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
St Bartholomew's Hospital
London, United Kingdom
Actively Recruiting
Research Team
J
Jawza Aldakhil
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here